HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Connexin 32 and luteolin play protective roles in non-alcoholic steatohepatitis development and its related hepatocarcinogenesis in rats.

Abstract
Non-alcoholic steatohepatitis (NASH) has the potential to lead to the development of cirrhosis and hepatocellular carcinoma (HCC). Connexin (Cx) 32, a hepatocyte gap-junction protein, plays a preventive role in hepatocarcinogenesis. However, the precise contribution of Cx32 in the development of NASH has not been established. In this study, we aimed to clarify the role of Cx32 and the chemopreventive effect of luteolin, an antioxidant flavonoid, on the progression of NASH and NASH-related hepatocarcinogenesis. Cx32 dominant negative transgenic (Cx32ΔTg) and wild-type (Wt) rats at 10 weeks of age were given diethylnitrosamine and fed methionine-choline-deficient diet (MCDD) or MCDD with luteolin for 12 weeks. MCDD induced steatohepatitis and fibrosis along with increased inflammatory cytokine expression and reactive oxygen species in the liver. These effects were more severe in Cx32ΔTg rats as compared with Wt rats, and significantly suppressed by luteolin in both genotypes. Concerning NASH-related hepatocarcinogenesis, the number of glutathione S-transferase placental form (GST-P)-positive foci was greater in Cx32ΔTg versus Wt rats, and significantly reduced by luteolin in Cx32ΔTg rats. Microarray analysis identified brain expressed, X-linked 1 (Bex1) as an upregulated gene in Cx32ΔTg rat liver. Quantitative RT-PCR and in situ hybridization revealed that increased Bex1 mRNA was localized in GST-P-positive foci in Cx32ΔTg rats, and the expression level was significantly decreased by luteolin. Moreover, Bex1 knockdown resulted in significant growth inhibition of the rat HCC cell lines. These results show that Cx32 and luteolin have suppressive roles in inflammation, fibrosis and hepatocarcinogenesis during NASH progression, suggesting a potential therapeutic application for NASH.
AuthorsHiroyuki Sagawa, Aya Naiki-Ito, Hiroyuki Kato, Taku Naiki, Yoriko Yamashita, Shugo Suzuki, Shinya Sato, Kosuke Shiomi, Akihisa Kato, Toshiya Kuno, Yoichi Matsuo, Masahiro Kimura, Hiromitsu Takeyama, Satoru Takahashi
JournalCarcinogenesis (Carcinogenesis) Vol. 36 Issue 12 Pg. 1539-49 (Dec 2015) ISSN: 1460-2180 [Electronic] England
PMID26494227 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: [email protected].
Chemical References
  • Connexins
  • Cytokines
  • Connexin 26
  • Luteolin
Topics
  • Animals
  • Carcinoma, Hepatocellular (etiology, metabolism)
  • Cell Line, Tumor
  • Cell Proliferation
  • Connexin 26
  • Connexins (metabolism, physiology)
  • Cytokines (metabolism)
  • Disease Progression
  • Hepatocytes (physiology)
  • Liver (metabolism, pathology)
  • Liver Neoplasms, Experimental (etiology, metabolism)
  • Luteolin (physiology)
  • Male
  • Non-alcoholic Fatty Liver Disease (complications, metabolism)
  • Oxidative Stress
  • Precancerous Conditions (metabolism, pathology)
  • Protective Factors
  • Rats, Transgenic
  • Gap Junction beta-1 Protein

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: